Print Page  Close Window

Press Releases

Keyword Search
 
Current | Archive
DateTitle 
02/08/18OraSure Technologies to Present at the LEERINK 7th Annual Global Healthcare Conference
BETHLEHEM, Pa., Feb. 08, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Douglas A. Michels, President and CEO, will speak to the investment community at the LEERINK 7th Annual Global Healthcare Conference.  The conference will be simultaneously webcast over the Internet. Mr. Michels is scheduled to speak on February 14, 2018, at approximately 3:30 pm Eastern Time (12:30 pm Pa... 
Printer Friendly Version
02/07/18OraSure Announces Record 2017 Fourth Quarter and Full-Year Financial Results
BETHLEHEM, Pa., Feb. 07, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, today announced its consolidated financial results for the fourth quarter and full-year ended December 31, 2017. Financial Highlights Consolidated net revenues for the fourth quarter of 2017 were $52.0 million, a 47% increase from the fourth quarter of 2016. Consolidated net product revenues were $50.2 million, represent... 
Printer Friendly Version
02/02/18OraSure Technologies Appoints Aradhana Sarin, M.D. to Board of Directors
BETHLEHEM, Pa., Feb. 02, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced the appointment of Dr. Aradhana Sarin, as a member of the Company's Board of Directors. Dr. Sarin will serve as a Class II Director with an initial term expiring at the Company’s 2020 Annual Meeting of Stockholders. She will also serve on the Audit Committee and Nominating and Corporate Governance Committee of th... 
Printer Friendly Version
01/17/18OraSure Technologies Earnings Conference Call Invitation
2017 Fourth Quarter Earnings Conference Call  Wednesday, February 7, 2018, 5:00 p.m. ET BETHLEHEM, Pa., Jan. 17, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR) has scheduled its regular earnings conference call covering 2017 fourth quarter financial results, 2018 first quarter financial guidance and certain business developments for 5:00 pm ET (2:00 pm PT) on Wednesday, February 7, 2018.  February 7, 2018 Schedule 4:00 p.m. ET 2017 fourth quarter financia... 
Printer Friendly Version
01/05/18OraSure Technologies to Present at the 36th Annual J.P. Morgan Healthcare Conference
BETHLEHEM, Pa., Jan. 05, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Douglas A. Michels, President and CEO, will speak to the investment community at the 36TH Annual J.P. Morgan Healthcare Conference.  The conference will be simultaneously webcast over the Internet. Mr. Michels is scheduled to speak on January 11, 2018, at approximately 10:30 AM Pacific Time (1:30 PM Easte... 
Printer Friendly Version
01/04/18OraSure Technologies Announces Management Succession Plan
Company Also Increases Revenue Forecast for Q4 2017 BETHLEHEM, Pa., Jan. 04, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced a succession plan for its President and Chief Executive Officer (“CEO”) and for its Chief Financial Officer and Chief Operating Officer.  The Company also announced updated revenue guidance for the fourth quarter of 2017. ... 
Printer Friendly Version
12/08/17OraSure Technologies Announces 2018 Annual Meeting Date
BETHLEHEM, Pa., Dec. 08, 2017 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR) today announced that its 2018 Annual Meeting of Stockholders is scheduled to be held at 10:00 a.m. EDT (7:00 a.m. PDT) on Tuesday, May 8, 2018.  This will be a completely virtual meeting, conducted as a live webcast.  Further details regarding the meeting will be provided at a later date. About OraSure Technologies OraSure Technologies is a leader in the development, manufacture and distribution of p... 
Printer Friendly Version
11/30/17OraSure Technologies Supports World AIDS Day With Innovative Programs to Enable HIV Testing
BETHLEHEM, Pa., Nov. 30, 2017 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced several new HIV testing-related initiatives, in recognition of World AIDS Day.  OraSure is working with The AIDS Institute to launch a grant program to encourage the development of innovative HIV self testing programs and collaborating with both The AIDS Institute and Walgreens to promote rapid HIV testing in cit... 
Printer Friendly Version
11/02/17OraSure Technologies to Present at the 2017 Canaccord Genuity Medical Technologies & Diagnostics Forum
BETHLEHEM, Pa., Nov. 02, 2017 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Douglas A. Michels, President and CEO, will speak to the investment community at the 2017 Canaccord Genuity Medical Technologies and Diagnostics Forum.  The conference will be simultaneously webcast over the Internet. Mr. Michels is scheduled to speak on November 9, 2017, at approximately 8:00 AM Eastern ... 
Printer Friendly Version
11/01/17OraSure Announces 2017 Third Quarter Financial Results
BETHLEHEM, Pa., Nov. 01, 2017 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, today announced its consolidated financial results for the three and nine months ended September 30, 2017. Financial Highlights Consolidated net revenues for the third quarter of 2017 were $42.3 million, a 31% increase from the third quarter of 2016. Consolidated net product revenues were $41.2 million, representing a 62% ... 
Printer Friendly Version